Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
Mar 8, 2007

Avax and Cancer Treatment Centers of America to Work on Personalized Vaccine for Ovarian Cancer

  • Cancer Treatment Centers of America reports that it plans to make a new cancer vaccine therapy for women with advanced-stage ovarian cancer by this summer. Avax Technologies will develop this treatment, which will use the patient's own tumor tissues.

    This patient-specific vaccine will be combined with chemotherapy delivered directly into the abdominal cavity. It will be offered to patients whose cancer have recurred after chemotherapy.

    Cancer Treatment Centers of America hopes to eventually make this form of vaccine available to treat other forms of cancer, including colorectal and lung cancer patients, as well as patients with malignant melanomas.



Be sure to take the GEN Poll

Scientifically Studying Ecstasy

MDMA (commonly known as the empathogen “ecstasy”) is classified as a Schedule 1 drug, which is reserved for compounds with no accepted medical use and a high abuse potential. Two researchers from Stanford, however, call for a rigorous scientific exploration of MDMA's effects to identify precisely how the drug works, the data from which could be used to develop therapeutic compounds.

Do you agree that ecstasy should be studied for its potential therapeutic benefits?

More »